01 February 2004
The effect of eight weeks of rabeprazole therapy on esophageal pH and motility and nitric oxide plasma level in patients with erosive esophagitisMaciej Świątkowski, Jacek Budzyński, Maria Kłopocka, Krzysztof Grad, Grzegorz Pulkowski, Beata Augustyńska, Karol Suppan, Jacek Fabisiak
Med Sci Monit 2004; 10(2): CR46-51 :: ID: 11593
Background:Esophageal clearance, an important pathogenetic factor in gastroesophageal reflux disease, depends mainly on motility. Motility disturbances can be secondary to gastric output reflux. Nitric oxide influences esophageal motility. The aim of this study was to determine the effect of eight weeks of gastric acid secretion suppression with rabeprazole (20 mg/day) on esophageal motility.Material/Methods: 20 patients with erosive esophagitis were studied. At study start and two weeks after the end of therapy, we recorded the results of interview, endoscopy, gastric and esophageal mucosa biopsy, 24-h esophageal pH-metry and manometry, and NO metabolites plasma concentration, determined spectrophotometrically (OXIS).Results: All patients reported improvement and remained free of symptoms two weeks later. In 60% of cases, improvement of esophageal mucosa appearance was observed in endoscopic and histological examination. In follow-up we found a significantly smaller number of acid gastrooesophageal refluxes (p<0.05), reduced DeMeester score for pH range >7 (p<0.05), and greater % of time within the esophageal pH range 6–7 (p<0.05). Other esophageal pH-metry and 24-h manometry parameters did not change significantly. NO metabolites plasma concentration increased significantly (p=0.039).
Conclusions: Clinical improvement after eight weeks of therapy with rabeprazole was connected with endoscopic changes only in 60% of our patients. Rabeprazole therapy did not influence esophageal motility, despite increased plasma levels of NO metabolites. Patients with erosive esophagitis need maintenance therapy, since as soon as two weeks after the end of treatment the % of monitoring time with esophageal pH<4 was similar to study start.
Keywords: 2-Pyridinylmethylsulfinylbenzimidazoles, Anti-Ulcer Agents - therapeutic use, Benzimidazoles - therapeutic use, Esophagitis, Peptic - blood, Esophagitis, Peptic - drug therapy, Esophagitis, Peptic - metabolism, Esophagitis, Peptic - physiopathology, Esophagus - metabolism, Esophagus - physiopathology, Gastrointestinal Motility - drug effects, Hydrogen-Ion Concentration, Manometry, Monitoring, Ambulatory, Nitric Oxide - blood, Nitrites - blood, Omeprazole - analogs & derivatives, Time Factors, 2-Pyridinylmethylsulfinylbenzimidazoles, Anti-Ulcer Agents - therapeutic use, Benzimidazoles - therapeutic use, Esophagitis, Peptic - physiopathology, Esophagus - physiopathology, Gastrointestinal Motility - drug effects, Hydrogen-Ion Concentration, Manometry, Monitoring, Ambulatory, Nitric Oxide - blood, Nitrites - blood, Omeprazole - analogs & derivatives, rabeprazole, Time Factors
04 June 2022 : EditorialEditorial: Acute Hepatitis of Unknown Origin in Children. Is Autoimmunity at Play?
Med Sci Monit 2022; 28:e937371
27 June 2022 : Clinical ResearchShoulder Injury Related to Vaccine Administration (SIRVA) in 16 Patients Following COVID-19 Vaccination Who...
Med Sci Monit In Press; DOI: 10.12659/MSM.937430
04 June 2022 : Clinical ResearchScreening for SARS-CoV-2 Infection in Students at the Medical University of Warsaw, Poland Between November...
Med Sci Monit 2022; 28:e936962
30 May 2022 : Clinical ResearchEffects of Wearing Face Masks on Exercise Capacity and Ventilatory Anaerobic Threshold in Healthy Subjects ...
Med Sci Monit 2022; 28:e936069
28 Jun 2022 : Meta-AnalysisUrodynamics in Early Diagnosis of Diabetic Bladder Dysfunction in Women: A Systematic Review and Meta-Analysis
Med Sci Monit In Press; DOI: 10.12659/MSM.937166
28 Jun 2022 : Clinical ResearchSerum Calprotectin – a NET Product – as a Biomarker of Disease Activity in Patients with Systemic Lupus Ery...
Med Sci Monit In Press; DOI: 10.12659/MSM.936534
28 Jun 2022 : Database AnalysisLINC00963 May Be Associated with a Poor Prognosis in Patients with Cervical Cancer
Med Sci Monit In Press; DOI: 10.12659/MSM.935070
Most Viewed Current Articles
30 Dec 2021 : Clinical ResearchRetrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review articleA Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...
Med Sci Monit 2022; 28:e936292
01 Nov 2020 : Review articleLong-Term Respiratory and Neurological Sequelae of COVID-19
Med Sci Monit 2020; 26:e928996